These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37921122)

  • 1. Cellular and molecular functions of SETD2 in the central nervous system.
    Mitchell B; Thor S; Piper M
    J Cell Sci; 2023 Nov; 136(21):. PubMed ID: 37921122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype correlation at codon 1740 of SETD2.
    Rabin R; Radmanesh A; Glass IA; Dobyns WB; Aldinger KA; Shieh JT; Romoser S; Bombei H; Dowsett L; Trapane P; Bernat JA; Baker J; Mendelsohn NJ; Popp B; Siekmeyer M; Sorge I; Sansbury FH; Watts P; Foulds NC; Burton J; Hoganson G; Hurst JA; Menzies L; Osio D; Kerecuk L; Cobben JM; Jizi K; Jacquemont S; Bélanger SA; Löhner K; Veenstra-Knol HE; Lemmink HH; Keller-Ramey J; Wentzensen IM; Punj S; McWalter K; Lenberg J; Ellsworth KA; Radtke K; Akbarian S; Pappas J
    Am J Med Genet A; 2020 Sep; 182(9):2037-2048. PubMed ID: 32710489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
    Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
    Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SETD2: from chromatin modifier to multipronged regulator of the genome and beyond.
    Molenaar TM; van Leeuwen F
    Cell Mol Life Sci; 2022 Jun; 79(6):346. PubMed ID: 35661267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Chromatin and Cytoskeletal Remodeling by SETD2.
    Park IY; Powell RT; Tripathi DN; Dere R; Ho TH; Blasius TL; Chiang YC; Davis IJ; Fahey CC; Hacker KE; Verhey KJ; Bedford MT; Jonasch E; Rathmell WK; Walker CL
    Cell; 2016 Aug; 166(4):950-962. PubMed ID: 27518565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SETD2-dependent H3K36me3 plays a critical role in epigenetic regulation of the HPV31 life cycle.
    Gautam D; Johnson BA; Mac M; Moody CA
    PLoS Pathog; 2018 Oct; 14(10):e1007367. PubMed ID: 30312361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3K36 trimethylation-mediated biological functions in cancer.
    Xiao C; Fan T; Tian H; Zheng Y; Zhou Z; Li S; Li C; He J
    Clin Epigenetics; 2021 Oct; 13(1):199. PubMed ID: 34715919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
    Ho TH; Park IY; Zhao H; Tong P; Champion MD; Yan H; Monzon FA; Hoang A; Tamboli P; Parker AS; Joseph RW; Qiao W; Dykema K; Tannir NM; Castle EP; Nunez-Nateras R; Teh BT; Wang J; Walker CL; Hung MC; Jonasch E
    Oncogene; 2016 Mar; 35(12):1565-74. PubMed ID: 26073078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SETD2 Methyltransferase Supports Productive HPV31 Replication through the LEDGF/CtIP/Rad51 Pathway.
    Mac M; DeVico BM; Raspanti SM; Moody CA
    J Virol; 2023 May; 97(5):e0020123. PubMed ID: 37154769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Chromatin-Cytoskeleton Link in Cancer.
    Giaccia AJ
    Mol Cancer Res; 2016 Dec; 14(12):1173-1175. PubMed ID: 27528705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase.
    Lam UTF; Chen ES
    Int J Biochem Cell Biol; 2022 Mar; 144():106155. PubMed ID: 34990836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shaping the cellular landscape with Set2/SETD2 methylation.
    McDaniel SL; Strahl BD
    Cell Mol Life Sci; 2017 Sep; 74(18):3317-3334. PubMed ID: 28386724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair.
    Li L; Wang Y
    J Biol Chem; 2017 Jul; 292(28):11951-11959. PubMed ID: 28546430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Heterogeneity and Different Phenotypes in Patients with
    Parra A; Rabin R; Pappas J; Pascual P; Cazalla M; Arias P; Gallego-Zazo N; Santana A; Arroyo I; Artigas M; Pachajoa H; Alanay Y; Akgun-Dogan O; Ruaud L; Couque N; Levy J; Porras-Hurtado GL; Santos-Simarro F; Ballesta-Martinez MJ; Guillén-Navarro E; Muñoz-Hernández H; Nevado J; Spanish OverGrowth Registry Initiative ; Tenorio-Castano J; Lapunzina P
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Regulated by H3K36me3.
    Yin J; Qi TF; Li L; Wang Y
    Anal Chem; 2023 Jun; 95(25):9672-9679. PubMed ID: 37296074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and enzymatic evidence for the methylation of the ACK1 tyrosine kinase by the histone lysine methyltransferase SETD2.
    Le Coadou L; Berthelet J; Mechaly AE; Michail C; Bui LC; Dairou J; Haouz A; Dupret JM; Rodrigues Lima F
    Biochem Biophys Res Commun; 2024 Feb; 695():149400. PubMed ID: 38160530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel cases expanding the phenotype of SETD2-related overgrowth syndrome.
    van Rij MC; Hollink IHIM; Terhal PA; Kant SG; Ruivenkamp C; van Haeringen A; Kievit JA; van Belzen MJ
    Am J Med Genet A; 2018 May; 176(5):1212-1215. PubMed ID: 29681085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders.
    Lee S; Menzies L; Hay E; Ochoa E; Docquier F; Rodger F; Deshpande C; Foulds NC; Jacquemont S; Jizi K; Kiep H; Kraus A; Löhner K; Morrison PJ; Popp B; Richardson R; van Haeringen A; Martin E; Toribio A; Li F; Jones WD; Sansbury FH; Maher ER
    Hum Mol Genet; 2023 Nov; 32(22):3123-3134. PubMed ID: 37166351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SET domain containing 2 (SETD2) influences metabolism and alternative splicing during myogenesis.
    Wiedner HJ; Torres EV; Blue RE; Tsai YH; Parker J; Giudice J
    FEBS J; 2022 Nov; 289(21):6799-6816. PubMed ID: 35724320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36.
    de Almeida SF; Grosso AR; Koch F; Fenouil R; Carvalho S; Andrade J; Levezinho H; Gut M; Eick D; Gut I; Andrau JC; Ferrier P; Carmo-Fonseca M
    Nat Struct Mol Biol; 2011 Jul; 18(9):977-83. PubMed ID: 21792193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.